LSP 7
Investments range between 30 million EUR and 60 million EUR.
LSP 7 seeks to invest in early-to-late-stage life sciences companies, developing novel and ground-breaking new medicines and technologies that provide solutions to unmet medical needs. LSP 7’s geographical focus is primarily Europe and occasionally the US.
Key Facts
- Status
Active
- Launch
2021
- Size
1B EUR
- SFDR classification
Art. 8
LSP Advisory B.V.
Johannes Vermeerplein 9
1071 DV Amsterdam, the Netherlands
Company Registration Number: 34296447
LSP Advisory B.V. is an alternative investment fund manager authorized and regulated in accordance with laws of the Netherlands.
Head of Fund
Partner and Head of EQT Life Sciences
Do You Want to Learn More?
We are eager to explore how we can achieve great things together.